Description: Amoéba S.A. produces biological biocides for the elimination of bacterial risk in water and human wounds. The company also offers biocontrol products for plant protection. It also develops applications using the amoeba Willaertia magna C2c Maky formation for plant protection. Amoéba S.A. was founded in 2010 and is based in Chassieu, France.
Home Page: amoeba-nature.com
38 Avenue de FrEres Montgolfier
Chassieu,
69680
France
Phone:
33 4 26 69 16 00
Officers
| Name | Title |
|---|---|
| Mr. Fabrice Plasson | Co-Founder, CEO, Chairman & Member of Management Board |
| Ms. Valerie Filiatre | Deputy GM, Member of Management Board & Director |
| Mr. Jean-Baptiste Eberst | Regulatory Affairs Director & Member of Management Board |
| Dr. Sandrine Demaneche | Scientific Director & Member of Management Board |
| Mr. Jean-Luc Souche | Bus. Developer of Biocontrôle & Member of Management Board |
Exchange: PA
Country: FR
Currency: Euro (€)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 10.6182 |
| Price-to-Sales TTM: | 412.4839 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 18 |